Newsroom archive

12 . 02 .2024
Making an impact
READ MORE
08 . 02 .2024
Press release
Galderma takes the ‘Face of Cetaphil®’ to the runway at New York City fashion week
  • Global release
READ MORE
07 . 02 .2024
Press release
Galderma launches ‘NEXT’, a ground-breaking trend report that unveils the future of aesthetics
  • Global release
READ MORE
02 . 02 .2024
Press release
Galderma celebrates 25 years of excellence in biostimulation with Sculptra® at the 2024 IMCAS
  • Global release
READ MORE
29 . 01 .2024
News story
The remarkable journey of Restylane, from the lab to the patient
READ MORE
IMCAS 2024 Galderma
25 . 01 .2024
News story
IMCAS 2024: Galderma’s scientific presentations
READ MORE
IMCAS 2024 Galderma aesthetic portfolio
25 . 01 .2024
Press release
IMCAS 2024: Galderma to present latest updates from its unparalleled aesthetics portfolio reinforcing its leadership position
  • Global release
READ MORE
Restylane® SHAYPE™
22 . 01 .2024
Press release
Galderma announces regulatory approval for Restylane® SHAYPE™, a new hyaluronic acid injectable designed for augmenting the chin region
  • Global release
READ MORE
22 . 01 .2024
Collaborative growth
READ MORE
17 . 01 .2024
Press release
TOXINS 2024: Galderma’s phase III RelabotulinumtoxinA results demonstrate positive efficacy and long duration of effect when treating frown lines and crow’s feet simultaneously
  • Global release
READ MORE